Ann Cunningham
Directeur/Membre du Conseil chez VISTAGEN THERAPEUTICS, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Ann Cunningham
Sociétés | Poste | Début | Fin |
---|---|---|---|
VISTAGEN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/01/2019 | - |
Corporate Officer/Principal | 01/05/2021 | - | |
Independent Dir/Board Member | 10/01/2019 | 01/05/2021 |
Historique de carrière de Ann Cunningham
Anciens postes connus de Ann Cunningham
Sociétés | Poste | Début | Fin |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2015 | 01/01/2018 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/1999 | 01/01/2013 |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - | - |
I3 Strategy Partners LLC | Fondateur | - | - |
Corporate Officer/Principal | - | - |
Formation de Ann Cunningham
Yale University | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 7 |
Israël | 2 |
Opérationnelle
Corporate Officer/Principal | 5 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
VISTAGEN THERAPEUTICS, INC. | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 2 |
---|---|
I3 Strategy Partners LLC | |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
- Bourse
- Insiders
- Ann Cunningham
- Expérience